Sun Pharmaceuticals reported INR47.44B in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Aspen Pharmacare ZAR 2.65B 3.41B Jun/2026
Bharat Petroleum INR -40.55B 125.98B Jun/2026
Cipla INR 13.88B 154.2M Sep/2026
Dr.Reddys Laboratories INR 8.6B 2.14B Jun/2026
Jiangsu Hengrui CNY 2.78B 379.11M Sep/2026
Sh Fosun Pharma CNY 1.61B 47.58M Sep/2026
Sun Pharmaceuticals INR 47.44B 3.26B Sep/2026
UPL INR 14.5B 21.08B Jun/2026